Bevacizumab (216974-75-3) ≥98%
Ácido cafeico éster de fenetil (CAPE) ≥98%
Cortexolona 17α-propionato ≥98%
Dolastatin 10 (110417-88-4) ≥98%
Dimeglumina de Fosaprepitant (EMEND) ≥98%
MMAD (Demethydolastatin 10) ≥98%
MMAF (Cloridrato) (1415246-68-2) ≥98%
Monometil auristatina E (MMAE) ≥98%
N-Boc-dolaproina (120205-50-7) ≥98%
Piridoxal-5-fosfato Monohidrato ≥98%
3-Methoxy-13-ethyl-gona-2,5 (10)-diene-17-ol ≥98%
N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide ≥98%